THE Department of Health has posted Price Disclosure Reductions for the 2017 Oct Cycle on the Pharmaceutical Benefits Scheme (PBS) website.
Determined price disclosure outcomes for this cycle were calculated in accordance with the National Health Act 1953 and National Health Regulations 2017, and show percentage price differences and exmanufacturer level prices.
For sponsors of F2 drug brands affected by flow-on price disclosure reductions, the Department advises it will communicate to the responsible person mid to late Jul.
Access the Excel version of the outcomes summary at pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jun 17